PAX6 and early-onset non-syndromic cataract: For disease modeling, CRISPR/Cas9 and TALEN approaches have successfully recapitulated human ocular pathologies including aniridia (Pax6 mutations), retinitis pigmentosa (RHO variants), and congenital cataracts (GJA8 defects).